ALS trial shows novel therapy is safe
An investigational treatment for an inherited form of
Lou Gehrig’s disease has passed an early phase clinical trial for
safety, researchers at the School of Medicine and Massachusetts General Hospital report. A mutated protein that causes an inherited form of Lou
Gehrig’s disease leads to clumps in the human cells, which are pictured.
Goate appointed director of Hope Center for Neurological Disorders
Alison Goate, PhD, has been named director of the Hope Center for Neurological Disorders, a partnership between Washington University School of Medicine in St. Louis and Hope Happens, a nonprofit foundation that supports research into neurodegenerative disorders.